Selective inhibition of human cytomegalovirus replication by naphthalenedisulfonic acid derivatives
- 1 March 1993
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 20 (3) , 223-233
- https://doi.org/10.1016/0166-3542(93)90022-b
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Therapy for herpesvirus infectionsCurrent Opinion in Infectious Diseases, 1991
- Alpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitroAntimicrobial Agents and Chemotherapy, 1991
- Clinical effect of BV-araU on varicella-zoster virus infection in immunocompromised patients with haematological malignanciesJournal of Antimicrobial Chemotherapy, 1991
- Novel sulfated polymers as highly potent and selective inhibitors of human immunodeficiency virus replication and giant cell formationAntimicrobial Agents and Chemotherapy, 1990
- Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virusAntimicrobial Agents and Chemotherapy, 1988
- Ganciclovir for Treatment of Renal Transplant-Associated Primary Cytomegalovirus PneumoniaThe Journal of Infectious Diseases, 1988
- Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidinesAntiviral Research, 1987
- Use of Ganciclovir to Treat Serious Cytomegalovirus Infections in Patients with AIDSThe Journal of Infectious Diseases, 1987
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- Biochemical aspects of the selective antiherpes activity of nucleoside analoguesBiochemical Pharmacology, 1984